Clinical Trial Update: Hypoxic Red Blood Cells in Sickle Cell Anemia [NA]

View source ↗

Summary

A clinical trial update on hypoxic red blood cells for sickle cell disease sponsored by Hemanext; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Hypoxic Red Blood Cells

Snippet

Sponsor: Hemanext | Conditions: Sickle Cell Anaemia, Sickle Cell Anemia Crisis | NA | Status: NOT_YET_RECRUITING